Characteristics | Evaluable patients (46) |
---|---|
Sex: F/M (%) | 4 (9)/42 (91) |
Age (years), mean (range) | 62 (39 to 82) |
WHO status: n (%) | |
0 | 20 (43) |
1 | 16 (35) |
2 | 3 (7) |
Undetermined | 7 (15) |
T/N stage: n (%) | |
cT2 | 6 (13) |
cT3 | 35 (76) |
cT4 | 5 (11) |
cN + a | 16 (35) |
Tumour location (third): n (%) | |
Upper | 13 (28) |
Middle | 18 (39) |
Lower | 10 (22) |
Upper + middle | 3 (7) |
Middle + lower | 2 (4) |